|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
212 a.a.
|
 |
|
|
|
|
|
|
|
217 a.a.
|
 |
|
|
|
|
|
|
|
118 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system/signaling protein
|
 |
|
Title:
|
 |
Crystal structure of human cd28 in complex with the fab frag mitogenic antibody (5.11a1)
|
|
Structure:
|
 |
Fab fragment of 5.11a1 antibody light chain. Chain: l. Fab fragment of 5.11a1 antibody heavy chain. Chain: h. Fragment: igv and igc1 domains. T-cell-specific surface glycoprotein cd28. Chain: c. Fragment: extracellular region. Synonym: tp44.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Homo sapiens. Human. Organism_taxid: 9606. Gene: cd28. Expressed in: cricetulus griseus. Expression_system_taxid: 10029.
|
|
Biol. unit:
|
 |
Hexamer (from PDB file)
|
|
Resolution:
|
 |
|
2.70Å
|
R-factor:
|
0.239
|
R-free:
|
0.282
|
|
|
Authors:
|
 |
E.J.Evans,R.M.Esnouf,R.Manso-Sancho,R.J.C.Gilbert,J.R.James, P.Sorensen,D.I.Stuart,S.J.Davis
|
Key ref:
|
 |
E.J.Evans
et al.
(2005).
Crystal structure of a soluble CD28-Fab complex.
Nat Immunol,
6,
271-279.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Jan-05
|
Release date:
|
15-Feb-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
protein binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Immunol
6:271-279
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a soluble CD28-Fab complex.
|
|
E.J.Evans,
R.M.Esnouf,
R.Manso-Sancho,
R.J.Gilbert,
J.R.James,
C.Yu,
J.A.Fennelly,
C.Vowles,
T.Hanke,
B.Walse,
T.Hünig,
P.Sørensen,
D.I.Stuart,
S.J.Davis.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Naive T cell activation requires signaling by the T cell receptor and by
nonclonotypic cell surface receptors. The most important costimulatory protein
is the monovalent homodimer CD28, which interacts with CD80 and CD86 expressed
on antigen-presenting cells. Here we present the crystal structure of a soluble
form of CD28 in complex with the Fab fragment of a mitogenic antibody.
Structural comparisons redefine the evolutionary relationships of CD28-related
proteins, antigen receptors and adhesion molecules and account for the distinct
ligand-binding and stoichiometric properties of CD28 and the related, inhibitory
homodimer CTLA-4. Cryo-electron microscopy-based comparisons of complexes of
CD28 with mitogenic and nonmitogenic antibodies place new constraints on models
of antibody-induced receptor triggering. This work completes the initial
structural characterization of the CD28-CTLA-4-CD80-CD86 signaling system.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Structure-based alignment of the CD28 and CTLA-4
extracellular domain sequences. Structures were aligned with
SHP as shown in Figure 1d. The following features are
highlighted: red, structurally equivalent residues conserved in
all mammalian CD28 and CTLA-4 sequences; green and yellow,
conserved CD28-specific (green) and CTLA-4-specific (yellow)
sequences; gray, -strands;
pale blue and orange, residues forming homodimeric contacts
(pale blue) and 5.11A1 Fab-contacts (orange); maroon and dark
blue, CTLA-4 residues that contact CD80 (maroon) and CD86 (dark
blue).
|
 |
Figure 5.
Figure 5. Proposed ligand- and 5.11A1 Fab complexes formed by
putative CD28 homodimers. (a) Orthogonal views of the
extracellular region of modeled CD80 -CD28 homodimer complexes.
With SHP, each of the CTLA-4 monomers from the CTLA-4 -CD80 (PDB
accession number 1i8l; dark blue) and CD86 -CTLA-4 (PDB
accession number 1i85; pale blue) complexes was superimposed in
turn on each of the monomers in the crystallographic CD28
homodimer (red). CD80 was then docked with CD28 according to the
mode of ligand binding seen for the CTLA-4 monomer. (b)
Superposition of CD28 and CTLA-4 homodimers as in Figure 4b,
after the docking of CD80 to both molecules, as in a, based on
the binding seen in PDB file 1i8l. (c) Two orthogonal views of
the complex formed by the crystallographic sCD28 homodimer (red)
and bivalently bound 5.11A1 Fab (green). The position of the
mutation disrupting nonmitogenic antibody binding in rat CD28 is
marked with light blue spheres. Top, horizontal line indicates
approximate position of the membrane; the line of view is
parallel to the membrane. Bottom, the line of view is toward the
T cell.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Immunol
(2005,
6,
271-279)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Verdino,
D.A.Witherden,
M.S.Ferguson,
A.L.Corper,
A.Schiefner,
W.L.Havran,
and
I.A.Wilson
(2011).
Molecular insights into γδ T cell costimulation by an anti-JAML antibody.
|
| |
Structure, 19,
80-89.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.F.Sonnen,
C.Yu,
E.J.Evans,
D.I.Stuart,
S.J.Davis,
and
R.J.Gilbert
(2010).
Domain metastability: a molecular basis for immunoglobulin deposition?
|
| |
J Mol Biol, 399,
207-213.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Azuma,
Y.Isaka,
H.Nomi,
T.Inamoto,
X.K.Li,
T.Hounig,
Y.Takabatake,
N.Ichimaru,
N.Ibuki,
K.Matsumoto,
T.Ubai,
Y.Katsuoka,
and
S.Takahara
(2010).
Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: regulatory T-cell expansion before engraftment may be important.
|
| |
Transplantation, 90,
1328-1335.
|
 |
|
|
|
|
 |
S.Radaev,
Z.Zou,
P.Tolar,
K.Nguyen,
A.Nguyen,
P.D.Krueger,
N.Stutzman,
S.Pierce,
and
P.D.Sun
(2010).
Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.
|
| |
Structure, 18,
934-943.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Hünig,
F.Lühder,
K.Elflein,
T.Gogishvili,
M.Fröhlich,
R.Guler,
A.Cutler,
and
F.Brombacher
(2010).
CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation.
|
| |
Med Microbiol Immunol, 199,
239-246.
|
 |
|
|
|
|
 |
C.Wu,
H.Ying,
S.Bose,
R.Miller,
L.Medina,
L.Santora,
and
T.Ghayur
(2009).
Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules.
|
| |
MAbs, 1,
339-347.
|
 |
|
|
|
|
 |
D.Hatherley,
S.C.Graham,
K.Harlos,
D.I.Stuart,
and
A.N.Barclay
(2009).
Structure of signal-regulatory protein alpha: a link to antigen receptor evolution.
|
| |
J Biol Chem, 284,
26613-26619.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Schönfeld,
G.Matschiner,
L.Chatwell,
S.Trentmann,
H.Gille,
M.Hülsmeyer,
N.Brown,
P.M.Kaye,
S.Schlehuber,
A.M.Hohlbaum,
and
A.Skerra
(2009).
An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.
|
| |
Proc Natl Acad Sci U S A, 106,
8198-8203.
|
 |
|
|
|
|
 |
G.C.Dong,
P.H.Chuang,
K.C.Chang,
P.S.Jan,
P.I.Hwang,
H.B.Wu,
M.Yi,
H.X.Zhou,
and
H.M.Chen
(2009).
Blocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptor.
|
| |
Pharm Res, 26,
375-381.
|
 |
|
|
|
|
 |
H.Bour-Jordan,
and
J.A.Bluestone
(2009).
Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.
|
| |
Immunol Rev, 229,
41-66.
|
 |
|
|
|
|
 |
K.Chattopadhyay,
E.Lazar-Molnar,
Q.Yan,
R.Rubinstein,
C.Zhan,
V.Vigdorovich,
U.A.Ramagopal,
J.Bonanno,
S.G.Nathenson,
and
S.C.Almo
(2009).
Sequence, structure, function, immunity: structural genomics of costimulation.
|
| |
Immunol Rev, 229,
356-386.
|
 |
|
|
|
|
 |
Y.Chen,
Y.Shi,
H.Cheng,
Y.Q.An,
and
G.F.Gao
(2009).
Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
|
| |
IUBMB Life, 61,
579-590.
|
 |
|
|
|
|
 |
E.Lázár-Molnár,
Q.Yan,
E.Cao,
U.Ramagopal,
S.G.Nathenson,
and
S.C.Almo
(2008).
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.
|
| |
Proc Natl Acad Sci U S A, 105,
10483-10488.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Singh,
S.Basu,
C.Camell,
J.Couturier,
R.J.Nudelman,
M.A.Medina,
J.R.Rodgers,
and
D.E.Lewis
(2008).
Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
|
| |
Eur J Immunol, 38,
1522-1532.
|
 |
|
|
|
|
 |
T.Gogishvili,
F.Elias,
J.L.Emery,
K.McPherson,
K.Okkenhaug,
T.Hünig,
and
K.M.Dennehy
(2008).
Proliferative signals mediated by CD28 superagonists require the exchange factor Vav1 but not phosphoinositide 3-kinase in primary peripheral T cells.
|
| |
Eur J Immunol, 38,
2528-2533.
|
 |
|
|
|
|
 |
B.S.Clay,
and
A.I.Sperling
(2007).
T-cell costimulation blockade in immunologic diseases: role of CD28 family members.
|
| |
Expert Rev Clin Immunol, 3,
383-393.
|
 |
|
|
|
|
 |
J.R.James,
S.S.White,
R.W.Clarke,
A.M.Johansen,
P.D.Dunne,
D.L.Sleep,
W.J.Fitzgerald,
S.J.Davis,
and
D.Klenerman
(2007).
Single-molecule level analysis of the subunit composition of the T cell receptor on live T cells.
|
| |
Proc Natl Acad Sci U S A, 104,
17662-17667.
|
 |
|
|
|
|
 |
T.Dowsing,
and
M.J.Kendall
(2007).
The Northwick Park tragedy--protecting healthy volunteers in future first-in-man trials.
|
| |
J Clin Pharm Ther, 32,
203-207.
|
 |
|
|
|
|
 |
U.Sester,
G.H.Wabnitz,
H.Kirchgessner,
and
Y.Samstag
(2007).
Ras/PI3kinase/cofilin-independent activation of human CD45RA+ and CD45RO+ T cells by superagonistic CD28 stimulation.
|
| |
Eur J Immunol, 37,
2881-2891.
|
 |
|
|
|
|
 |
E.L.Beukema,
M.P.Brown,
and
J.D.Hayball
(2006).
The potential role of fowlpox virus in rational vaccine design.
|
| |
Expert Rev Vaccines, 5,
565-577.
|
 |
|
|
|
|
 |
E.Lazar-Molnar,
S.C.Almo,
and
S.G.Nathenson
(2006).
The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function.
|
| |
Cell Immunol, 244,
125-129.
|
 |
|
|
|
|
 |
L.D.Friend,
D.D.Shah,
C.Deppong,
J.Lin,
T.L.Bricker,
T.I.Juehne,
C.M.Rose,
and
J.M.Green
(2006).
A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant.
|
| |
J Exp Med, 203,
2121-2133.
|
 |
|
|
|
|
 |
M.J.Kenter,
and
A.F.Cohen
(2006).
Establishing risk of human experimentation with drugs: lessons from TGN1412.
|
| |
Lancet, 368,
1387-1391.
|
 |
|
|
|
|
 |
M.L.Dustin,
S.Y.Tseng,
R.Varma,
and
G.Campi
(2006).
T cell-dendritic cell immunological synapses.
|
| |
Curr Opin Immunol, 18,
512-516.
|
 |
|
|
|
|
 |
M.L.Schmitz,
and
D.Krappmann
(2006).
Controlling NF-kappaB activation in T cells by costimulatory receptors.
|
| |
Cell Death Differ, 13,
834-842.
|
 |
|
|
|
|
 |
N.Beyersdorf,
T.Hanke,
T.Kerkau,
and
T.Hünig
(2006).
CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.
|
| |
Autoimmun Rev, 5,
40-45.
|
 |
|
|
|
|
 |
S.J.Davis,
and
P.A.van der Merwe
(2006).
The kinetic-segregation model: TCR triggering and beyond.
|
| |
Nat Immunol, 7,
803-809.
|
 |
|
|
|
|
 |
W.A.Teft,
M.G.Kirchhof,
and
J.Madrenas
(2006).
A molecular perspective of CTLA-4 function.
|
| |
Annu Rev Immunol, 24,
65-97.
|
 |
|
|
|
|
 |
D.M.Compaan,
L.C.Gonzalez,
I.Tom,
K.M.Loyet,
D.Eaton,
and
S.G.Hymowitz
(2005).
Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex.
|
| |
J Biol Chem, 280,
39553-39561.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Collins,
V.Ling,
and
B.M.Carreno
(2005).
The B7 family of immune-regulatory ligands.
|
| |
Genome Biol, 6,
223.
|
 |
|
|
|
|
 |
N.Beyersdorf,
S.Gaupp,
K.Balbach,
J.Schmidt,
K.V.Toyka,
C.H.Lin,
T.Hanke,
T.Hünig,
T.Kerkau,
and
R.Gold
(2005).
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
|
| |
J Exp Med, 202,
445-455.
|
 |
|
|
|
|
 |
N.Beyersdorf,
T.Hanke,
T.Kerkau,
and
T.Hünig
(2005).
Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
|
| |
Ann Rheum Dis, 64,
iv91-iv95.
|
 |
|
|
|
|
 |
P.Holliger,
and
P.J.Hudson
(2005).
Engineered antibody fragments and the rise of single domains.
|
| |
Nat Biotechnol, 23,
1126-1136.
|
 |
|
|
|
|
 |
P.S.Linsley
(2005).
New look at an old costimulator.
|
| |
Nat Immunol, 6,
231-232.
|
 |
|
|
|
|
 |
S.Bhatia,
M.Edidin,
S.C.Almo,
and
S.G.Nathenson
(2005).
Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling.
|
| |
Proc Natl Acad Sci U S A, 102,
15569-15574.
|
 |
|
|
|
|
 |
S.Y.Tseng,
M.Liu,
and
M.L.Dustin
(2005).
CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse.
|
| |
J Immunol, 175,
7829-7836.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |